Jeffrey E. Lancet
机构：Moffitt Cancer Center · ORCID：0000-0002-7751-7310
发表论文 943 篇 · 总被引 15819 次 · h-index 62
代表论文
- American Society of Hematology 2025 guidelines for treating newly diagnosed acute myeloid leukemia in older adults (2025 · Blood Advances · 被引 15)
- CPX-351 selectively benefits patients with AML and myelodysplasia-related mutations in the pivotal randomized trial (2026 · Blood Advances · 被引 8)
- Posttransplant MRD monitoring by TP53 duplex sequencing with APR-246 + azacitidine maintenance predicts outcomes (2025 · Blood Advances · 被引 2)
- Cardiovascular Adverse Events During Venetoclax‐Based Treatment in Acute Myeloid Leukemia (2026 · Journal of the American Heart Association · 被引 1)
- POSTER: MDS-515: Durable Complete Remission Following HMA Therapy in Higher-Risk MDS Is Not Fully Determined by Baseline Disease Biology (2026 · Clinical Lymphoma Myeloma & Leukemia)
- POSTER: MDS-646: Real-World Outcomes of Imetelstat: Interrogating Safety, Efficacy, and Predictors of Response in Heavily Pretreated Lower-Risk Patients With MDS (2026 · Clinical Lymphoma Myeloma & Leukemia)